New apalutamide study opens for prostate cancer

February 14, 2018

A new phase 3 study at Providence Cancer Institute will compare the effectiveness of three different treatment regimens in men with biochemically recurrent prostate cancer:

Experimental arm: apalutamide, an investigational, next-generation oral androgen receptor (AR) inhibitor, plus degarelix, a hormonal therapy used to reduce testosterone
Experimental arm: apalutamide and degarelix plus abiraterone acetate and prednisone
Control arm: degarelix alone

“Apalutamide (ARN-509) reduced the risk of metastasis or death by 72% in patients with nonmetastatic castration-resistant prostate cancer,” according to findings from the phase 3 SPARTAN trial reported in OncLive on Feb. 5. The SPARTAN trial, published in the New England Journal of Medicine on Feb. 8, found that “median metastasis-free survival was more than 2 years longer” for men who received apalutamide. Read more in the New York Times.

Brendan Curti, M.D., the principal investigator of the new three-arm study at Providence Cancer Institute, is a medical oncologist and director of genitourinary oncology research at the Earle A. Chiles Research Institute.

See Providence study details here:

A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

More prostate cancer studies

This study is one of three clinical trials open to men with prostate cancer at Providence Cancer Institute. See all prostate cancer studies.

To refer patients to any of these studies, call Providence Cancer Institute’s Clinical Research office at 503-215-2614 or visit oregon.providence.org/clinical-trials.

Welcome to your journey for creating a healthier you

New apalutamide study opens for prostate cancer

See Providence study details here:

More prostate cancer studies

Previous Article

Next Article

New apalutamide study opens for prostate cancer

See Providence study details here:

More prostate cancer studies

Previous Article

Next Article

Most Recent Articles

Hospital receives American Heart Association Get with The Guidelines-Stroke Gold Plus award for commitment to prioritizing quality care for stroke patients

As of September 12, 2022, Providence Mission Hospital Laguna Beach will close its Chemical Dependency program which is an elective inpatient and outpatient medical detoxification service for adults.

A new “Providence” sign was recently installed above the front entrance at Providence Santa Rosa Memorial Hospital.

Providence researcher awarded National Institutes of Health grant to lead a new lab focusing on the discovery of novel inflammatory pathways in cancer that are targets for therapeutic intervention.

Working toward health equity in our community

Dr. Shephal Doshi co-leads international clinical trial to evaluate Conformal Medical’s novel CLAAS implant

Learn about the health benefits of a traditional Asian diet at this free, online education event presented by Providence Cancer Institute and the Asian Health & Service Center.

When we talk about how Providence helps others, you might think first of health care for patients. But there are many more ways we support people in our communities.

Leading healthcare professionals interested in the treatment of patients with neuroendocrine tumors to gather in June for a comprehensive medical conference held in Oregon.

Although skin protection is important year-round, the summer is a good time to review helpful tips and tricks to help keep your skin safe while you enjoy the outdoors.

Two investigator-initiated trials sponsored by the Earle A. Chiles Research Institute are currently recruiting patients with either advanced HER2-positive or HR positive/HER2 negative breast cancer.

Minimally invasive technique allows for small, 5 mm incisions to remain hidden beneath the waistline

Providence researchers recruit adult patients with solid cancers for phase I clinical trial of genetically engineered, adoptively transferred T cells.

Providence St. Vincent Medical Center and Oregon Nurses Association labor negotiation teams are pleased to announce that we have have reached a tentative agreement.

The Children’s Hospital at Providence provides free immunization clinics for children 10 a.m.-1 p.m. on the first Saturday of each month in Providence Alaska Medical Center Suite A351 (A Tower).

Adoptive cell therapy study at Providence Cancer Institute gives hope to woman with metastatic pancreatic cancer. Results may lead to new treatments and longer lives for people with advanced cancers.

A Florida woman with advanced pancreatic cancer is hopeful after receiving an experimental treatment in a clinical trial at Providence Cancer Institute that shrunk her tumors.

In 2021, the Valdez Food Bank received $20,000 from Providence Alaska to add the Rental Deposit Assistance Program to its services.